Eurotranspharma relies on certificates from DQS

If you want to be successful in the hotly contested pharmaceutical distribution market, you have to operate at the highest level in terms of quality, reliability and safety. This applies in particular to serving the "last mile", the transportation of pharmaceuticals from the hub or depot to the end user such as pharmacies or hospitals. A suitable, but not always mandatory measure as proof of quality for the services offered is certification in accordance with the GDP guidelines, preferably in conjunction with ISO 9001. You can find out more about this in this article and the following interview with the pharmaceutical logistics company Eurotranspharma (ETP).

Certification of pharmaceutical logistics

Pharmaceutical logistics poses major challenges for the logistics service providers involved in the supply chain. In order to meet these requirements, Eurotranspharma Deutschland GmbH relies on DQS. Certification in accordance with the GDP guideline and certification in accordance with ISO 9001:2015 reflect the company's understanding of quality and awareness of secure supply chains within pharmaceutical logistics.

 

What is GDP?

GDP (Good Distribution Practice) is a guideline of the European Commission (2013/C 343/01), which refers to the "good distribution practice of medicinal products for human use" in the area of wholesale distribution, i.e. storage, delivery and export. The current version has been valid since November 5, 2013; the first version dates back to 1994. The main aim of the guideline is to prevent counterfeit medicines from entering the market, but also to ensure that the quality of the products is maintained across all wholesale activities, for example with regard to the cold chain.

gdp-certification-dqs-medicines stock shipments
Loading...

Who needs GDP certification?

GDP certification is only mandatory for companies that operate as medicinal product wholesalers and must therefore have an official wholesale authorization. In this case, the tests for conformity with the GDP guidelines are generally carried out by the authority that issued the respective permit or authorization.

For companies that operate exclusively as transporters of pharmaceutical products, a GDP certificate is not mandatory, but is an important proof of compliance with the GDP guidelines in a competitive environment. Such non-official GDP certifications are offered exclusively by private-sector certifiers.

As in many other areas in which certifications are offered in accordance with a standard, specification or guideline, companies should also ensure that they only commission an accredited certifier, such as DQS, when checking compliance with the GDP guidelines. This is because the value and credibility of a certificate depend heavily on the reputation of the issuing certification body.

 

ISO 9001 - a suitable basis for the GDP guidelines

A certified quality management system in accordance with ISO 9001 introduced in parallel with GDP provides a valuable basis with regard to the requirements formulated in the GDP regulations - for example in Chapter 1. It also provides a suitable framework, independent of the GDP regulations, for every company to align its processes with customer and market expectations, identify potential risks and opportunities and ensure the continuous improvement of the management system via the PDCA cycle.

About the reasons for pharmaceutical logistics certification

In this interview, Andrea Blum, Quality Director at ETP, and Managing Director Steffen Segelke provide information about the reasons for GDP certification and why the focus was on quality in every respect.

Interview: Andrea Blum and Steffen Segelke

Andrea Blum

Quality Director bei ETP

Steffen Segelke

Geschäftsführer von ETP

DQS: The German branch of Eurotranspharma (ETP) was only founded in September 2023 - how did you manage to implement the requirements of ISO 9001 and the GDP guidelines ready for certification in such a short time?

Andrea Blum: I can name two key pillars here: When setting up ETP Germany, we were able to rely on a team with pharmaceutical experience in the management functions - just for fun, we added it up and came up with more than 200 years of experience. We have also been active in other countries for quite a long time and have had the above-mentioned certifications there for years. Our colleagues have actively supported us - especially in the first few months.

ETP Germany is primarily active on the so-called "last mile" - certification in accordance with both GDP and ISO 9001 is not actually mandatory. Do you see the certifications as a competitive advantage in a highly competitive environment?

Steffen Segelke: Above all, pharmaceutical distribution has something to do with trust. Can I entrust my goods to a partner who can only help the patient if they are in perfect condition? Many of the people involved are well-known in the pharmaceutical market, yet ETP was a new company in Germany. The certifications are of course an important element in building trust.

So the certifications are primarily based on a strategic decision?

Steffen Segelke: Strategically, yes, but from two perspectives: on the one hand towards the customer as a basis, and on the other hand internally - especially to ensure that the processes really interlock in a company that is being built up and that we are constantly reviewing ourselves.

Which GDP requirement required the most effort?

Andrea Blum: There is no such thing as "one big requirement". The challenge was rather the simultaneity of the projects, namely the establishment of an operational network - infrastructure, personnel, equipment, all of this, the establishment and implementation of the GDP and "ISO 9001" compliant quality management system, here above all processes, training, self-inspection, qualification and finally the attainment of certification maturity. The usual approach is to take these steps in succession. We could not have achieved this without our dedicated team and a common goal.

At ETP, in addition to the continuous improvement process from ISO 9001, you also have your own optimization system for your processes, called CAPA - can you give us an example to explain the difference to the well-known and proven PDCA cycle?

Andrea Blum: I think that the methods of ISO 9001 and GDP complement rather than differ from each other. CAPA focuses on identifying, investigating and eliminating deviations and thus contributes to continuous improvement. Our basic procedure follows the PDCA cycle.

What specific benefits did ISO 9001 have for you in terms of implementing the GDP guidelines?

Andrea Blum: ISO 9001 forms the basis, the structure of our quality management system and provides us with (process) orientation, if you like. Due to the similarities between the two standards, we were able to supplement the special requirements of the pharmaceutical industry for the transportation of medicines. We have thus created the conditions for establishing stable processes, continuously improving them and ensuring the quality and integrity of pharmaceutical products. The combination of ISO 9001 and GDP contributes directly to our values. We focus on our customers, quality, integrity and innovation. And particularly important: our employees.

It is well known that non-accredited parties also offer their services in the area of ISO 9001 certification - what do you think of this?

Steffen Segelke: You mention the supposedly "easier way", but that was never an option for us. As I said earlier, we also commission certification for our internal processes - not just as a pure marketing tool. And in the pharmaceutical sector in particular, many customers not only rely on the certificate, but also regularly carry out their own audits. It would be fatal if we failed these audits because we had previously opted for the "easier way". We have found DQS to be a real sparring partner, whose expertise helps us to become even better.

Fortunately, you opted for an accredited certifier - how did you come across DQS?

Andrea Blum: The criteria for selecting a certifier were competence and reliability. As a leading certification company, DQS was naturally on our list.

Steffen Segelke: As a company in the process of being set up, the choice of partner for certification is particularly important. For me, it's comparable to a structural engineer checking the construction. You need a partner with expertise and a standing of their own, who will also ask critical questions. We associated these attributes with DQS in advance and made our decision accordingly.

How did you find the specific work of our audit team, Andreas Völkerding and Martin Campe?

Andrea Blum: The entire Eurotranspharma team worked for months towards the initial certification. Of course, we were all a bit tense and nervous. However, the DQS audit team managed to convey a positive feeling to the employees. In addition to their expertise in the standards, the auditors also had the necessary logistics experience. The auditors scrutinized our processes with technical know-how and professional skill, and it was also confirmed that certification by DQS is not the "easy way" mentioned earlier.

Would you describe the DQS audits as value-adding for ETP, and if so, can you give us a small example?

Andrea Blum: The audits were of course carried out to verify compliance with the requirements of ISO 9001 and GDP. The fact that the auditors focused on the individuality of our company, our goals and our potential for further development beyond compliance with standards was very beneficial for us. Constructive discussions opened our eyes to other perspectives and approaches. One example is the implementation of internal audits: not to carry out the traditional department or specialist area audit, but to continue the process-oriented approach and look at the functionality of the processes and the interaction of the specialist areas across departments. Process improvements can thus be initiated holistically.

Would you recommend DQS as a certification company?

Andrea Blum: A clear YES! We have come to know and appreciate DQS and its auditors as a competent and trustworthy partner.

That makes us very happy! Ms. Blum, Mr. Segelke, thank you very much for the interesting interview!

Eurotranspharma Germany - temperature-controlled pharmaceutical transports on the last mile

Eurotranspharma (ETP) is a pharmaceutical logistics company active throughout Europe and one of six companies belonging to the Walden Group, a logistics specialist founded in France in 1951 with around 5,400 employees. ETP Germany was founded at the end of 2023 as the youngest of the nine European country organizations to date and specializes in the so-called "last mile", the transport of pharmaceutical products to end customers such as pharmacies, pharmaceutical wholesalers or hospitals. In addition to the hub in Malsfeld, the company currently operates 13 depots with a total of around 9,000 individual shipments per day, with ten more depots planned.

ETP Germany successfully underwent a GDP certification audit by DQS in September 2024; certification in accordance with ISO 9001 followed in April 2025. Since September 2024, ETP Germany has been the only pharmaceutical logistics provider to offer deliveries for both the temperature range of 15 to 25 °C and 2 to 8 °C from one and the same network. ETP Germany has been connected to the European ETP network since October 2024

pharmalogistic-gdp-dqs-eurotranspharma-truck4.jpg
Loading...

Pharmaceutical logistics certification as a sustainable success factor

Conclusion

Certification in pharmaceutical logistics - particularly in accordance with GDP and in addition to ISO 9001 - is much more than a voluntary quality feature. It is increasingly becoming a decisive differentiating factor in a highly competitive market in which trust, safety and uncompromising quality are paramount. The path taken by Eurotranspharma Germany impressively demonstrates that a strategic focus on certified processes not only meets the expectations of customers and interested parties, but also contributes to continuous internal improvement.

The choice of an accredited and experienced certification partner such as DQS creates demonstrable added value. With this commitment, Eurotranspharma underlines its pioneering role on the "last mile" of pharmaceutical logistics: the claim to deliver pharmaceutical products safely, reliably and in compliance with the highest quality standards is firmly anchored in the company's culture and daily processes.

For logistics service providers in the pharmaceutical industry, professional pharmaceutical logistics certification is not only a competitive advantage, but also a clear commitment to integrity, transparency and sustainable excellence in the service of patient safety and customer satisfaction.

Trust and expertise

Our texts and brochures are written exclusively by our standards experts or long-standing auditors. If you have any questions about the text content or our services to our author, please send us an e-mail: [email protected]

Note: For reasons of better readability, we use the generic masculine. However, the directive includes persons of all gender identities where necessary for the statement.

Author

Andreas Voelkerding

Expert and project manager at DQS for the transport and logistics sector. Andreas Voelkerding is responsible for numerous industry-specific standards, including TAPA FSR/TSR/PSR, GDP and ISO 28000. As an auditor, his many years of experience are in demand both nationally and internationally, especially in logistics, air and sea freight.

Loading...

You Might Also Enjoy These Reads

Discover more articles that dive deep into related themes and ideas.
Blog
Loading...

ISO 9001:2026: Key Changes, Timeline & Transition Checklist

Blog
Loading...

Impact to Clients in China from QMS Certification Rules_Ed 2025

Blog
Loading...

Emerging trends and their significance